Abstract:Besides a reduction of L-type Ca2+-currents (Ca(V)1), muscarine and the peptidic M1-selective agonist, MT-1, reduced currents through Ca(V)2.1 (P/Q) and Ca(V)2.2 (N) Ca2+ channel types. This modulation was strongly blocked by the peptide MT-7, a specific muscarinic M1-type receptor antagonist but not significantly reduced by the peptide MT-3, a specific muscarinic M4-type receptor antagonist. Accordingly, MT-7, but not MT-3, blocked a muscarinic reduction of the afterhyperpolarizing potential (AHP) and decreas… Show more
“…1E) of the ''unitary'' IPSCs recorded from SPN3SPN connections (Fig. 1F) was found (32,(40)(41)(42). First, shape index plots (graphing half widths vs. rise times) of mean IPSCs (GP3NSt, empty circles; SPN3SPN, filled circles) showed no significant differences between these two connections ( Fig.…”
Section: Resultsmentioning
confidence: 86%
“…IPSCs between SPNs were also recorded after antidromic stimulation of striofugal axons at the globus pallidus (GP) (called the GP3NSt connection to avoid confusion) ( Fig. 1 A) (32,(40)(41)(42) in the presence of glutamate receptor blockers (10 M CNQX plus 50 M APV). These responses were sensitive to 10 M bicuculline (Fig.…”
“…1E) of the ''unitary'' IPSCs recorded from SPN3SPN connections (Fig. 1F) was found (32,(40)(41)(42). First, shape index plots (graphing half widths vs. rise times) of mean IPSCs (GP3NSt, empty circles; SPN3SPN, filled circles) showed no significant differences between these two connections ( Fig.…”
Section: Resultsmentioning
confidence: 86%
“…IPSCs between SPNs were also recorded after antidromic stimulation of striofugal axons at the globus pallidus (GP) (called the GP3NSt connection to avoid confusion) ( Fig. 1 A) (32,(40)(41)(42) in the presence of glutamate receptor blockers (10 M CNQX plus 50 M APV). These responses were sensitive to 10 M bicuculline (Fig.…”
“…Activation of A 1 -receptors mainly reduce Ca V 2.2 channels current [40,41]. Once Ca v 2.2 current was blocked, low adenosine concentrations (100 nM) could no longer reduce Ca 2+ -current further in any cell tested, suggesting that main current component targeted by A 1 -receptors is Ca V 2.2.…”
Section: +mentioning
confidence: 92%
“…Solution changes used a microvalve system (Lee; Essex, CT, USA) allowing reversibly applications [41]. Substances used were: ω-conotoxin GVIA (ω-CgTx-GVIA), ω-agatoxin TK (ω-AgTx), tetrodotoxin (TTX) (from Alomone Labs; Jerusalem, Israel); nicardipine, adenosine (Sigma-Aldrich-RBI, St. Louis, MO).…”
Section: Drugsmentioning
confidence: 99%
“…A main reason is, precisely, the relation of these channels with neuronal excitability and transmitter release [5,21,23,33,40,41,46,48,67]. SPNs express several classes of Ca V 1 and Ca V 2 channels [5,6,8,9,38,40,42,48].…”
-currents, while A 2A -type receptors enhanced current through Ca V 1 channels. Because these channels have opposing actions on cell discharge, these differences explain in part why iSPNs may be more excitable than dSPNs. It is demonstrated that intrinsic voltage-gated currents expressed in SPNs are effectors of purinergic signaling that therefore play a role in excitability.
Striatal cholinergic interneurons (ChIs) provide acetylcholine tone to the striatum and govern motor functions. Nicotine withdrawal elicits physical symptoms that dysregulate motor behavior. Here, the role of striatal ChIs in physical nicotine withdrawal is investigated. Mice under RNAi‐dependent genetic inhibition of striatal ChIs (ChIGI) by suppressing the sodium channel subunit NaV1.1, lessening action potential generation and activity‐dependent acetylcholine release is first generated. ChIGI markedly reduced the somatic signs of nicotine withdrawal without affecting other nicotine‐dependent or striatum‐associated behaviors. Multielectrode array (MEA) recording revealed that ChIGI reversed ex vivo nicotine‐induced alterations in the number of neural population spikes in the dorsal striatum. Notably, the drug repurposing strategy revealed that a clinically‐approved antimuscarinic drug, procyclidine, fully mimicked the therapeutic electrophysiological effects of ChIGI. Furthermore, both ChIGI and procyclidine prevented the nicotine withdrawal‐induced reduction in striatal dopamine release in vivo. Lastly, therapeutic intervention with procyclidine dose‐dependently diminished the physical signs of nicotine withdrawal. The data demonstrated that the striatal ChIs are a critical substrate of physical nicotine withdrawal and that muscarinic antagonism holds therapeutic potential against nicotine withdrawal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.